GlassScriptPhysician profile
Carl Lee Ritch
NPI 1922622356
$3,960.88
in general payments reported to CMS, 2019-2025
10 companies · $2,027 in 2025
The $2,027 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $70.25 · 2021: $419 · 2022: $499 · 2023: $175 · 2024: $771 · 2025: $2,027.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,889 · Travel and Lodging: $976 · Entertainment: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,888.94 |
| Travel and Lodging | $976.45 |
| Entertainment | $107.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,638.38 | 2020-2025 | Precision7, Precision 1, Total30 |
| Coopervision INC. | $420.24 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $144.76 | 2020-2021 | |
| Lombart Brothers, INC. | $138.32 | 2024 | Opd-III |
| Bausch & Lomb Americas INC. | $132.55 | 2022-2023 | Infuse |
| Optos, INC. | $122.37 | 2021-2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Amgen INC. | $122.35 | 2024 | Tepezza |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $117.18 | 2020-2021 | |
| Optovue, INC. | $84.73 | 2021 | |
| Visionix USA, INC | $40.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Ritch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.